United States v. Lamarre

712 F.3d 612
CourtCourt of Appeals for the First Circuit
DecidedApril 1, 2013
Docket10-2340, 10-2486
StatusPublished
Cited by18 cases

This text of 712 F.3d 612 (United States v. Lamarre) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Lamarre, 712 F.3d 612 (1st Cir. 2013).

Opinion

TORRUELLA, Circuit Judge.

Following a jury trial, Defendanb-Appel-lants Patrick J. Gelin (“Gelin”) and Miche-line Lamarre (“Lamarre”) were each convicted under 18 U.S.C. §§ 1347 and 1349 for making fraudulent claims to, and obtaining payment from, insurance companies participating in Massachusetts’ no-fault automobile insurance program. 1 They appeal their convictions, arguing first that the district court erred in ruling that the defrauded insurance companies constituted “health care benefit programs” within the jurisdictional reach of § 1347. Gelin and Lamarre also argue that the district court (1) erred in concluding that their scheme affected interstate commerce as is required for a constitutionally valid application of § 1347; and (2) abridged their Fifth and Sixth Amendment rights in denying proposed voir dire questions concerning the ethnic minority group to which they belong. Finding no error by the district court, we affirm.

I. Background

Gelin was the owner of Premium Care Physical Therapy (“Premium”), a physical *615 therapy clinic in Brockton, Massachusetts. Lamarre worked as an “on-call” physical therapist at Premium and was generally present at the clinic on Mondays and Wednesdays. The sequence of events leading up to Gelin and Lamarre’s convictions follows.

In April 2002, Gelin hired Sharon Little (“Little”) as the marketing director for Premium. Little was responsible for bringing new patients to Premium and for getting the clinic into better functioning order. Eventually she also became Premium’s manager and Gelin’s assistant, helping him with the billing of insurance companies for treatments provided to clinic patients. While discharging those duties, Little stumbled onto patient charts indicating that Lamarre treated patients on days when Little knew Lamarre was not at the clinic. When Little asked what was going on, Gelin told her that Premium was submitting fraudulent charges to insurance companies with the help of Lamarre. According to Little’s testimony, Gelin and Lamarre would submit fraudulent claims to providers of Massachusetts’ no-fault automobile insurance and request payment for physical therapy that they never rendered. If the fraudulent claims were paid, Lamarre would receive up to 15% of the proceeds as a commission for her participation in the scheme, and Gelin would keep the rest.

Between 2003 and 2004, Little heard Gelin instruct Lamarre to “finish off’ charts more than 20 times. She also saw Lamarre forging patient charts that Gelin had given her, and saw Gelin forging injury claim application forms on behalf of patients. When Little protested to Gelin about their need to forge charts given Premium’s success, he responded that she was overreacting to “a little white-collar crime” and told her not to worry about it. Lamarre later told Little that the submission of fraudulent claims was Gelin’s idea, and while she was not happy with it, she did need the extra money to pay off her student loans.

Little testified that Gelin eventually concluded that she could not be trusted to keep quiet about Premium’s billing practices. He therefore hired a “general chief manager” and instructed him to keep an eye on Little. By August 2004, Little had had enough and told Gelin that she would not do “this illegal shit” anymore, walked out of the office, and “never went back.” Sometime thereafter Little informed the National Insurance Crime Bureau about the fraudulent scheme at Premium.

Gelin and Lamarre were each indicted on nine counts of health care fraud, § 1347, and one count of conspiracy to commit health care fraud, § 1349. During the voir dire, Gelin’s counsel requested that the court pose the following question to the venire: “Patrick Gelin is a black Haitian-Ameriean. Do you have any feelings about black Haitian-Amerieans or any other minority group that might affect your ability to sit as a fair and impartial juror in this case?” Lamarre, also a Haitian-American, joined Gelin’s request, advancing concerns regarding the racial overtone of evidence the government intended to introduce at trial. Specifically, Gelin and Lamarre pointed to Little’s deposition testimony, where she used derogatory terms to refer to Gelin’s Haitian background and made reference to voodoo and witch doctors. She also referred to Gelin as the godfather of the Haitian community.

The government did not object to the voir dire question but stated that it was unnecessary, even though it anticipated that Little would offer testimony concerning Gelin’s statement that his fraudulent activity was a “white person’s crime,” and that he was “not doing what [African-Americans] do, selling drugs in the street.” *616 The government also admitted that it would introduce testimony of former employees who would state that Gelin treated African-Americans differently than people from the Haitian community.

The district court refused to pose the voir dire question, stating that it was not aware of “anything in the facts of the case that would suggest any potential for racial bias to be a prominent feature of the case.” The court also stated its view that defense counsel “vastly overstated the danger of racial bias in an average jury in 2010” and “presume[d] the existence of racial bias in jurors the way we might have 50 years ago, maybe 25 years ago.” But in present times, the court then added, “we have to acknowledge, I think, the reality of social progress. So it is-just as a general matter against a social background that there’s no need to inject the issue into the case.”

Nevertheless, the court did emphasize to the venire the need for a jury “that is composed of people who are completely fair-minded and impartial as to the parties involved in the case and as to the issues presented.” It followed up with specific inquiries about whether any juror was employed by law enforcement or insurance companies, and whether any of them had been the victim of fraud or other crimes. The court also asked potential jurors whether they had “any personal belief, attitudes, experiences, potential biases that would interfere with [their] ability to be a fair-minded and impartial juror in this case.”

At trial, the government introduced 16 witnesses, including Little, several patients whose treatment charts Little had identified as containing false entries, employees from the defrauded insurance companies, several of Premium’s employees, and an FBI agent. Some of the witnesses testified that Gelin and Lamarre had documented therapy sessions with car accident victims when the patients were not in Massachusetts or when Lamarre, who signed off on the treatments, was not in the clinic. For example, one of the government’s witnesses testified that Premium had submitted a claim for 30 treatment days “provided” during a period of time in which he was away attending college in Iowa. 2 Furthermore, one of Premium’s physical therapy assistants testified that the charts reflecting treatments supposedly administered by Lamarre were not consistent with the days that Lamarre actually worked at the clinic.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dekovic v. Rubio
Tenth Circuit, 2026
Teles De Menezes v. Rubio
First Circuit, 2025
United States v. Coleman
First Circuit, 2025
United States v. Martinez-Alberto
79 F.4th 7 (First Circuit, 2023)
United States v. Perez-Rodriguez
13 F.4th 1 (First Circuit, 2021)
United States v. Takesian
945 F.3d 553 (First Circuit, 2019)
United States v. Cezaire
First Circuit, 2019
United States v. Casanova
886 F.3d 55 (First Circuit, 2018)
United States v. Latorre-Cacho
874 F.3d 299 (First Circuit, 2017)
United States v. Parker
872 F.3d 1 (First Circuit, 2017)
United States v. Bray
First Circuit, 2017
United States v. Rivera-Ruperto
852 F.3d 1 (First Circuit, 2017)
United States v. Solomon Manamela
612 F. App'x 151 (Third Circuit, 2015)
United States v. Frenchitt Collins
774 F.3d 256 (Fifth Circuit, 2014)
United States v. Delgado-Marrero
744 F.3d 167 (First Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
712 F.3d 612, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-lamarre-ca1-2013.